Allspring Global Investments Holdings LLC Trims Position in Agilent Technologies, Inc. (NYSE:A)

Allspring Global Investments Holdings LLC trimmed its position in Agilent Technologies, Inc. (NYSE:A) by 0.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 335,607 shares of the medical research company’s stock after selling 842 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Agilent Technologies were worth $48,834,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in A. Livelsberger Financial Advisory bought a new position in Agilent Technologies in the 4th quarter worth $26,000. MV Capital Management Inc. raised its stake in shares of Agilent Technologies by 120.7% in the fourth quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock worth $27,000 after buying an additional 105 shares during the period. VisionPoint Advisory Group LLC purchased a new position in shares of Agilent Technologies during the 4th quarter valued at about $29,000. Rise Advisors LLC grew its stake in shares of Agilent Technologies by 527.8% during the 1st quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after acquiring an additional 190 shares during the period. Finally, Baystate Wealth Management LLC increased its holdings in Agilent Technologies by 107.3% in the 4th quarter. Baystate Wealth Management LLC now owns 257 shares of the medical research company’s stock worth $36,000 after acquiring an additional 133 shares in the last quarter.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $130.00, for a total value of $254,540.00. Following the completion of the sale, the chief executive officer now directly owns 25,185 shares in the company, valued at $3,274,050. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Agilent Technologies news, SVP Dominique Grau sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the completion of the transaction, the senior vice president now owns 49,486 shares in the company, valued at $6,595,494.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $130.00, for a total value of $254,540.00. Following the transaction, the chief executive officer now directly owns 25,185 shares in the company, valued at approximately $3,274,050. The disclosure for this sale can be found here.

Agilent Technologies Stock Up 0.3 %

NYSE A opened at $126.13 on Thursday. The stock has a 50 day moving average price of $139.17 and a 200-day moving average price of $138.35. Agilent Technologies, Inc. has a one year low of $96.80 and a one year high of $155.35. The company has a market capitalization of $36.80 billion, a P/E ratio of 29.80, a P/E/G ratio of 4.40 and a beta of 1.05. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.64 and a current ratio of 2.15.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, May 29th. The medical research company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.19 by $0.03. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The business had revenue of $1.57 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same quarter last year, the business earned $1.27 earnings per share. Agilent Technologies’s quarterly revenue was down 8.4% compared to the same quarter last year. As a group, equities analysts predict that Agilent Technologies, Inc. will post 5.25 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be paid a dividend of $0.236 per share. The ex-dividend date of this dividend is Tuesday, July 2nd. This represents a $0.94 annualized dividend and a yield of 0.75%. Agilent Technologies’s payout ratio is currently 22.22%.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Evercore ISI lifted their price target on shares of Agilent Technologies from $126.00 to $130.00 and gave the company an “in-line” rating in a report on Tuesday. UBS Group dropped their target price on shares of Agilent Technologies from $155.00 to $141.00 and set a “neutral” rating for the company in a report on Thursday, May 30th. Barclays cut their price target on Agilent Technologies from $135.00 to $125.00 and set an “underweight” rating for the company in a research note on Friday, May 31st. Citigroup lowered their price objective on Agilent Technologies from $145.00 to $135.00 and set a “neutral” rating on the stock in a research report on Thursday, May 30th. Finally, Oppenheimer increased their target price on Agilent Technologies from $67.00 to $90.00 and gave the stock an “outperform” rating in a research report on Tuesday, March 26th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $137.13.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.